HANNAH STONE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2001-10-31 HANNAH STONE has served as a director of the Company since June 1997. Ms. Stone is Managing Director of Sandler Capital Management, which she joined in 1993. Sandler Capital Management, through affiliates, is involved in the management of 21st Partners, 21st T-E and 21st Foreign. Ms. Stone also serves as a director of several private companies.
2003-03-10 HANNAH STONE has served as a director of the Company since June 1997. Ms. Stone is Managing Director of Sandler Capital Management. The Stock Option and Compensation Committee is composed of Mr. Graham and Ms. Stone. The Audit Committee is composed of Mr. Farrell, Ms. Stone and Mr. Quinson. In October 2002, Ms. Stone resigned as a member of the audit committee and was replaced by Mr. Kanon. The Company currently compensates its outside directors for services rendered in their capacity as directors at a rate of $1,000 per meeting. The Company's internal directors are not compensated for attendance at meetings.

Data sourced from SEC filings. Last updated: 2026-03-05